Clinical audit suggestions: osteoporosis
Osteoporosis is a disease characterised by low bone mass and structural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to fracture. Osteoporosis leads to nearly nine million fractures annually worldwide.
Pathway
National Institute for Health and Care Excellence (NICE) pathway for diagnosis, treatment and care of people with osteoporosis
Clinical knowledge summary
NICE clinical knowledge summary:Osteoporosis – prevention of fragility fractures
Audit criteria
Patients at increased risk of fragility fracture should have their fracture risk formally assessed with a validated tool such as NICE guidance on Osteoporosis: assessing the risk of fragility fractures .
Risk factors include:
prior fragility fracture
known low bone mineral density (BMD)
body mass index (BMI) <19kg/m2
parental history of hip fracture
glucocorticoid use (any dose for ≥ three months)
alcohol use ≥ three units daily
rheumatoid arthritis
housebound
smoking
secondary causes of osteoporosis – these include:
inflammatory bowel disease (e.g. Crohn's disease)
malabsorption (e.g. coeliac disease)
cystic fibrosis
hyperthyroidism
hyperparathyroidism
vitamin D insufficiency
immobilisation (e.g. resulting from CVA or Parkinson's disease)
chronic obstructive pulmonary disease
diabetes melitus type 1
chronic renal and hepatic disease.
Other audit and case-finding projects can be found at Osteoporosis Resources for Primary Care. This piece of work is the result of a joint initiative between the Royal College of General Practitioners and the National Osteoporosis Society. The aim of the project was to equip GPs, practice nurses and other members of the practice team with relevant information about osteoporosis in light of the inclusion of the condition in the Quality and Outcomes Framework.
Resources
Osteoporosis Case Finding in Primary Care (Patient.co.uk) – for Read codes and case-finding information
FRAX – 10-year fragility fracture risk, adjusted for RA
QFracture-2012 – 10-year fragility fracture risk, adjusted for RA
Previous
Clinical audit
Clinical audit suggestions: gout
Clinical audit suggestions: low back pain
Clinical audit suggestions: osteoarthritis
Clinical audit suggestions: osteoporosis
Clinical audit suggestions: polymyalgia rheumatica
Clinical audit suggestions: rheumatoid arthritis
Clinical audit suggestions: corticosteroids
Clinical audit suggestions: disease-modifying anti-rheumatic drugs (DMARDs)
Clinical audit suggestions: non-steroidal anti-inflammatory drugs (NSAIDs)
Hospital-prescribed drugs
Investigations for musculoskeletal problems
Next
Back to Clinical audit